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Abstract
Background: Zambia is a sub-Saharan country with one of the highest prevalence rates of HIV, currently estimated
at 14%. Poor nutritional status due to both protein-energy and micronutrient malnutrition has worsened this
situation. In an attempt to address this combined problem, the government has instigated a number of strategies,
including the provision of antiretroviral (ARV) treatment coupled with the promotion of good nutrition. High-
energy protein supplement (HEPS) is particularly promoted; however, the impact of this food supplement on the
nutritional status of people living with HIV/AIDS (PLHA) beyond weight gain has not been assessed. Techniques for
the assessment of nutritional status utilising objective measures of body composition are not commonly available
in Zambia. The aim of this study is therefore to assess the impact of a food supplement on nutritional status using
a comprehensive anthropometric protocol including measures of skinfold thickness and circumferences, plus the
criterion deuterium dilution technique to assess total body water (TBW) and derive fat-free mass (FFM) and fat
mass (FM).
Methods/Design: This community-based controlled and longitudinal study aims to recruit 200 HIV-infected
females commencing ARV treatment at two clinics in Lusaka, Zambia. Data will be collected at four time points:
baseline, 4-month, 8-month and 12-month follow-up visits. Outcome measures to be assessed include body height
and weight, body mass index (BMI), body composition, CD4, viral load and micronutrient status.
Discussion: This protocol describes a study that will provide a longitudinal assessment of the impact of a food
supplement on the nutritional status of HIV-infected females initiating ARVs using a range of anthropometric and
body composition assessment techniques.
Trial Registration: Pan African Clinical Trial Registry PACTR201108000303396.
Background
Zambia is among the five countries in sub-Saharan
Africa with the most serious HIV/AIDS epidemic [1]. In
2007, the HIV prevalence rate in adults was reported to
be 14%, a slight but non-significant decrease from 16%
in the 2001-2002 (Zambia Demographic Health Survey)
[2]. Zambia also suffers from high rates of both macro-
and micro-nutrient malnutrition. Indicators of nutri-
tional status in children under five years of age show
the prevalence of stunting, underweight and wasting at
45%, 15% and 5%, respectively. The prevalence of vita-
min A deficiency and anaemia in the same age group is
54.1% and 52.9%, respectively [2-4]. Malnutrition com-
promises immunity to infectious diseases, which in turn
aggravates malnutrition. The so-called malnutrition
infection complex (MIC) is a well known phenomenon
and the presence of HIV has made the situation worse.
HIV/AIDS also drives household vulnerability to food
insecurity, which contributes to households not having
access to adequate food to meet the daily nutrient
requirements for individuals to lead active and healthy
lives [5].
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Following the first diagnosed AIDS case in Zambia
in 1984, the Government has put in place a number
of strategies and interventions to fight the epidemic
[6]. These interventions include preventive approaches
to reduce new cases of HIV/AIDS infection and the
provision of free ARV treatment [7]. To achieve the
full benefit of ARV treatment, adequate nutrition is
essential, therefore the government promotes good
nutrition and in particular, HEPS is provided to
PLHA, including those on ARV treatment. Commonly,
HIV-infected individuals have reduced food intake due
to the effect of the HIV infection compounded by sec-
ondary opportunistic infection. This has a marked
effect on appetite leading to reduced food intake and
consequently, to weight loss [8]. Weight loss in PLHA
is dissimilar to that observed in severely malnourished
individuals, as FFM rather than FM diminishes with
the HIV infection. With the advent of ARV treatment,
multiple additional nutritional changes which lead to
obesity and the metabolic syndrome have been
observed [9].
Typically, measurement of body weight is the nutri-
tional assessment approach used to monitor health out-
comes in resource-limited countries, with gain in
absolute weight being the desired short-term outcome.
Less common is the use of other anthropometric
approaches such as circumference and skinfold thick-
ness measurement, or objective body composition tech-
niques. Bioelectrical impedance analysis (BIA) is a quick,
non-invasive and relatively inexpensive body composi-
tion assessment technique [10,11] suitable for routine
clinical use in the developing world. Skinfold anthropo-
metry has been used to estimate body composition in
HIV-infected persons using predictive equations how-
ever; as equations are population-specific, they need to
be validated against a gold standard method before
being used on another population [12].
This study aims to measure the impact of HEPS on
the nutritional status and body composition of HIV-
infected people who commence ARV treatment, over a
12-month period. In this study, body composition will
be assessed using the stable isotope dilution technique
to quantify TBW and subsequently FFM, along with
body height, weight, BMI, skinfold and circumference
measurements plus BIA.
Food intake and micronutrient status will also be
assessed in the study population. This is based on the
premise that the prevalence of macronutrient and
micronutrient malnutrition, particularly vitamin A and
iron, worsens with the HIV/AIDS epidemic. Further, as
CD4 counts and viral load are important biomarkers of
health status in this population, they will also be
measured.
Methods/Design
Study design
This is a community-based controlled and longitudinal
study. The study population will be comprised of HIV-
infected females commencing ARV treatment at two
Lusaka Urban clinics, Matero Reference Clinic (MRC)
and Matero Main Clinic (MMC). The study participants
will be allocated to either the experimental group and
receive HEPS or control group and not receive HEPS.
Participants will be randomly assigned to either group
by the sister-in-charge at each clinic. Data will be col-
lected at four time points across the 12-month study:
baseline (0 months), 4-months, 8-months and 12-
months follow-up. The study protocol has been
approved by the University of Zambia Research Ethics
Committee (approval ref 017-02-07).
Recruitment
Participants will be recruited to the study from women
who report to each clinic for care and support after
being diagnosed as HIV-positive at a Voluntary and
Counselling Treatment (VCT) centre in Lusaka. The
clinics will collect blood samples for CD4 count, viral
load and liver function tests from each study participant
and subsequent appointment times to collect their
results will be given. Blood samples collected in all gov-
ernment clinics in Lusaka are analyzed at the Centre for
Infectious Diseases Research Laboratories in Lusaka.
Upon receipt of results the sister-in-charge at each clinic
will screen the results and identify those individuals
considered to be eligible to commence ARV treatment
based mainly on a CD4 count of 350 cells/μL or less.
Using a tracking system which consists of the partici-
pant’s residential address and telephone number (or that
of their spouse or guardian), eligible participants will be
reminded of their clinic appointments. For those who
do not have telephone contacts, a clinic staff member
will visit them at their respective homes to inform them
of their appointment and the need to report to the clinic
and the Sister-in-Charge for ART. The sister will then
invite each client one by one and explain the nature of
the study. Once the client agrees to participate they will
be asked to sign a consent form in duplicate or if they
are unable to write, they will provide a thumb print.
The Sister-in-Charge will sign as a witness. The original
copy will be filed at the clinic while the duplicate copy
will be stored by the Principal Investigator (PI) in a
locked filing cabinet at the project office.
Once the client has consented to the study a project
ID number will be assigned and the PI will meet with
each individual to work through the information sheet
in detail. During this period, each client is provided with
another opportunity to clarify any issues or concerns
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before embarking on the study. Trained nursing and
project staff will take routine measurements such as
blood pressure and body temperature and also collect a
urine sample for a pregnancy test. This will be followed
by a full physical examination by a medical practitioner.
Once the client has been certified as eligible to com-
mence ARV treatment and meets all inclusion criteria
she will be enrolled as a study participant.
Participants will be eligible if they are HIV-positive
with CD4 count 350 cells/μL or less; are commencing
ARV treatment; female aged 20-40 years; not mentally
challenged and agree to participate in the study. Partici-
pants will be ineligible if clinically unstable or with
other medical conditions (e.g., elevated creatinine),
which will prevent them from commencing on ARV
treatment, if they are pregnant or plan to fall pregnant
during the study.
Allocation to study groups
On the day of recruitment (baseline) after completing all
body composition assessments and physical examina-
tion, the sister-in- charge will cut pieces of papers, equal
to the number of participants enrolled that day. Half of
the papers will bear the word ‘Soya’ while the other half
will have ‘No Soya’ written on them. The papers will be
folded several times to conceal the writing and then
mixed. Each participant will be asked to pick one and
read loud for the sister-in-charge to record the group
assignment in the study registry book.
Intervention/experimental group
A total of 120 kg of the food supplement will be given
to each participant in the intervention or experimental
group during the 12-month study period. To ensure a
fresh supply of the food supplement and to minimise
sharing or selling, the participants will be given 10 kg of
the food supplement, enough for 30 days, and will be
asked to collect 10 kg each month from the clinic. Each
time the participant travels to collect the food supple-
ment they will be given Zambian kwacha (ZMK) equiva-
lent to approximately US$3 to cover the cost of
transport from their home to the clinic. HEPS is a mix-
ture of extruded maize meal and soya flour to which
sugar and a vitamin-mineral mix have been added. Por-
ridge is the common form in which HEPS is consumed.
The participants will be given instructions on how to
prepare the porridge from the HEPS and will be advised
to consume it at least two times a day. In addition, they
will receive further advice on the importance of good
nutrition at the same time of taking ARV medication.
Control group
Participants in the control group will not receive any
food supplement but instead will receive a box of
detergent paste and a packet of toilet soap once every 4
months at each scheduled follow-up visit. This group
will also receive the same nutritional advice as the
experimental group including medication.
Training of project staff
The International Atomic Energy Agency (IAEA) will
provide Fellowship training for two project team mem-
bers, the PI and a senior laboratory technician. Training
in body composition measurement techniques will be
undertaken at Queensland University of Technology,
Brisbane, Australia. The trained project staff will further
refine their skills prior to training the field staff by com-
pleting pilot testing on 20 volunteer participants
recruited from amongst the staff members at the
research institution. This will assist in the preparation of
a locally adapted training manual for subsequent use in
the training of all field staff.
The use of BIA, skinfold thickness, circumference and
isotope dilution techniques to assess nutritional status is
not common in Zambia. Therefore, prior to implement-
ing the field work a high level advocacy and awareness
meeting for policy makers in public, private and interna-
tional organisations dealing with nutrition and health
will be organised to seek their support. Mixed presenta-
tions covering nutritional challenges, the consequences
of HIV infection, interventions, traditional nutrition
assessment tools and their limitations and state-of-the-
art techniques will be made. Presenters will include
renowned health practitioners, nutritionists, research
scientists from various arms of government, and a tech-
nical expert from the IAEA.
Recruitment and training of field staff
Six nurses, three from each of the two selected study
site clinics, and two medical practitioners, one from
each clinic, will be recruited and trained as field staff
across two comprehensive training sessions. The aim of
the first training session will be to introduce the anthro-
pometric and body composition techniques and meth-
odologies using both theory and practical
demonstrations. In addition, a pre-test will be conducted
at one of the clinics using 10 volunteer students from
the Natural Resource Development College (NRDC) in
Lusaka who are undertaking a food and nutrition
diploma course. Ten students will be selected for the
pre-test to provide the opportunity for a real world
practical application of their theoretical work in class as
this is the anticipated maximum number of participants
likely to be recruited in a day.
The second training session will involve on-site train-
ing for the field staff at the respective clinics selected
for the study. The training will be conducted a week
prior to commencement of the recruitment of
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participants and baseline data collection. The aim of the
on-site training will be to acquaint field staff with the
sequence of events to be followed during data collection,
have a final hands-on practice of the techniques and
work out other logistical issues including space, labora-
tory and cafeteria facilities. A total of 50 female volun-
teer students from NRDC will be used as participants,
10 per day with three days training to be conducted at
Matero Reference Clinic and two days at Matero Main
Clinic. Students will be given appointment times to
report to the clinics and will be refunded for transport
expenses. However, measurements during the on-site
training will be limited to body composition assessment.
Physical examination by the medical practitioner, gravi-
dex test, and collection of blood for assessing total
blood count, CD4 counts, viral load and micronutrient
analysis will not be undertaken. Similarly, tests relating
to HIV/AIDS status and counselling will not form part
of the pre-test.
Outcome measures
Anthropometry
Weight will be measured to the nearest 0.1 kg using a
Seca digital portable scale (model 813 Seca gmbh & Co.,
Hamburg, Germany) with the participant wearing mini-
mal clothing. Participants will be briefed about the
importance of taking accurate weight measurements.
HIV-infected people lose a considerable amount of
weight before they seek medical care and clothes
become very loose. To keep clothes in shape, many
women wear several layers of clothing and if left
unchecked, these could add considerably to the body
weight. Each participant will be given a pre-weighed
piece of cloth (two yard) to tie around their body at the
time of measurement. All other clothes and accessories,
with exception of underwear, will be removed.
Height will be measured to the nearest 0.1 cm using a
free-standing Seca stadiometer (model 225 Seca gmbh &
Co., Hamburg, Germany). A standard procedure for
measuring height, without shoes and socks, will be fol-
lowed. Height, if accurately measured, should remain
constant across the duration of the study. However, it is
common for African women to have elaborate hair
styles that cannot be undone for the purpose of taking
height measurements, therefore, where necessary, extra
care will be taken in the estimation of height to account
for such hair styles.
Circumference and skinfold thickness measurements
will be done simultaneously since similar procedures are
used to locate the sites. Three circumference measure-
ments: mid-upper arm, abdominal at the level of the
umbilicus, and hip will be taken using a Seca plastic
measuring tape. Skinfold thickness will be measured at
five sites: bicep, triceps, subscapular, iliac crest and
medial calf using a Harpenden skinfold caliper (British
Indicators Ltd., London, UK) with all measurements
taken on the right side of the body. Standard procedures
for the location of sites and taking measurements will be
followed [13]. All measurements will be taken in tripli-
cate. Circumference and skinfold thickness measures
provide an indication of regional fat distribution. FM as
a percentage of total body weight will be calculated
from the sum of skinfold thickness measurements
(biceps, triceps, subscapular and suprailiac sites = ∑4SF)
and prediction equations [14].
Bioelectrical impedance analysis
Impedance will be measured using a multi-frequency
BIA (SFB7 model, ImpediMed Limited, Queensland,
Australia) device according to the manufacturer’s
instructions. This will include ensuring that the battery
is fully charged and the equipment is calibrated; partici-
pants will be asked not to exercise or take alcohol dur-
ing the 24 hours before measurement. Participants will
rest in a supine position for 5-10 min on a medical
examination couch prior to measurement. A very mild
current (50 ohms), imperceptible to the participant,
passes through the body’s water compartments. The
SFB7 device takes measurements at 256 discrete fre-
quencies, logarithmically spaced from 4 kHz to 1000
kHz. The software in the device enables the prediction
of TBW and by extrapolation, FFM and FM. These pre-
diction equations are population-specific hence there is
a need to validate the results using the isotopic techni-
que before the BIA device can be used routinely on
HIV-infected people. Prior to analysis, each participant’s
height, weight, age and sex will be entered into the
device.
Total Body Water
A procedural requirement is that the deuterium oxide
dose be administered to a fasted individual or at least
two hours after taking a meal. Prior to administering
the dose, a baseline saliva sample will be collected from
each participant and used to determine the natural base-
line enrichment of the isotope in the body. Participants
will also be asked whether they have fasted and if not,
the time they had their last meal will be noted. Partici-
pants will report to the clinic at 08.00 h and the deuter-
ium dose will be administrated between 10.30 h and
11.00 h (as an additional precaution against participants
having eaten recently). A pre-weighed dose of 30 g deu-
terium oxide will be administered orally to each partici-
pant regardless of body weight with the aid of a straw,
followed by a rinse of the bottle (approximately 50 mL
of mineral water) to ensure consumption of the full
dose. Participants will be told not to eat, drink or void
their bladder within one hour of ingesting the dose and
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30 min before collecting the saliva sample. During the
equilibration period, the consumption of drinks and
emptying the bladder will be restricted. If this is neces-
sary, volumes will be noted. However, due to the
extended period of fasting, and period of assessment,
participants will be provided with a standard lunch and
drink and the volume of the drink will be noted. The
first post-dose saliva sample will be collected at four
hours after taking the dose and the second post-dose
sample at five hours to ensure equilibration.
Saliva samples (4.5 mL) will be collected using a cot-
ton wool ball and with the aid of a syringe and trans-
ferred into pre-labelled 5 mL vials and subsequently,
pre-labelled zip-lock bags. Saliva samples will be trans-
ported in an insulated box cooled with freeze packs to
the laboratory at NISIR and stored at -20°C for later
analysis.
Determination of TBW
Deuterium oxide enrichment of the saliva samples will
be measured using a Fourier Transform Infrared (FTIR
8400S; Shimadzu, Vienna, Austria) spectrometer. This
FTIR is available at the NISIR laboratories in Lusaka,
Zambia. Prior to enrichment measurement of the saliva
the FTIR will be calibrated using a 99.9 atom % deuter-
ium oxide standard solution of known composition. The
standard will be prepared according to the method
described in the IAEA guidelines [15] by weighing deu-
terium oxide and diluting with local drinking water
(bottled mineral water) to give a solution of about 1000
mg/kg by weight enrichment. This enrichment of the
FTIR calibration standard will be verified using an Iso-
tope Ratio Mass Spectrometer (IRMS) at a reference
laboratory (Iso-Analytical Laboratory, UK). A range of
enrichments will likely be encountered during analysis
of saliva collected from the participants; the accuracy of
deuterium oxide analysis over the range will therefore
need to be checked by preparing a calibration curve.
The 1000 mg/kg enrichment represents the maximum
expected body water enrichment. The calibration proce-
dure will involve preparation of deuterium oxide by
gravimetric dilution (between 0 and 2000 mg/kg) and
measuring their enrichment by the FTIR. Accuracy will
be determined from the gradient and linear regression
through the data of the calibration curve should be
close to 1.
The FTIR will be set up according to IAEA guidelines
[15-17]. Once ready to take measurements, the analyti-
cal precision of the FTIR will be checked before and
after completing the measurements for the day by first
taking measurements of local drinking water and the
calibrator standard enrichment solution 3 times each
and ensuring that the coefficient variation (CV) of less
than 1% is achieved. Once the precision is ascertained
the enrichment of the saliva samples for the participants
will be measured. The spectrum of local drinking water
will be obtained first as a background followed by mea-
suring the spectrum of the standard in the range 2300-
2800 cm-1. Thereafter the spectrum of the saliva will be
taken by first obtaining the spectrum of the pre-dose
saliva as background then followed by that of the post-
dose samples (collected at 4 and 5 h). Prior to obtaining
the spectra of the saliva, the samples will be thawed to
room temperature and then centrifuged (Model 5702R,
Eppendorf AG, Hamburg, Germany) at 3000 rpm for 10
minutes. Once the spectrum has been obtained it will
be exported as a text file and further processed using
the “isotope.exe” programme developed by the Medical
Research Centre (MRC) [17]. This program enables the
translation of the spectrum intensity into excess concen-
tration of deuterium oxide in the saliva sample. The
dilution space will be calculated from the concentration
of deuterium oxide in the saliva using a standard for-
mula. TBW (kg) will be calculated from the dilution
space after correcting for non aqueous dilution of deu-
terium oxide. The dilution space is 1.04 times TBW.
The FFM will be derived from TBW using a hydration
coefficient, that is the fraction of FFM comprised of
water and this is constant in adult, 0.732. Once FFM
has been estimated, FM and percentage body fat will be
calculated.
Quality control will be done in accordance with the
IAEA guidelines [15]. The equation proposed by the
IAEA for use as a quality control measure in TBW (kg)
= 7.4 × height3 (m3), where TBW from each post-dose
sample is used with the height of each participant. Since
this equation will not be derived from our population in
particular, a range incorporating the 95% confidence
interval for the above relationship (< 5.7 × height3 or >
9.6 × height3) also proposed by the IAEA for assessment
of accuracy, will be considered. The TBW samples fall-
ing outside this range will be excluded from the analysis.
The variation in TBW values depends on both the
degree of analytical precision and natural biological
variation.
Clinical assessment
Physical examinations will be undertaken by a medical
practitioner and fasting blood sample collected. At base-
line and at 12-month assessments, three vials of blood
will be collected, for CD4 count, viral load and micronu-
trient analysis. At 4-month and 8-month follow-ups, all
measures except micronutrient analysis will be underta-
ken. Part of the blood sample for CD4 count will be
used to measure full blood count which will be deter-
mined at the clinic laboratory. Blood samples will be
processed at the clinic laboratory to separate the plasma
from the blood cell for CD4 and viral load and the
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serum for micronutrient analysis. The plasma for viral
load and serum for micronutrient determination will
immediately be stored at -20°C at the clinic until ship-
ment, while the plasma for CD4 count will be stored at
room temperature, packaged and couriered by FedEx to
the TDRC in Ndola.
Dietary intake study
A 3-day weighed food record coupled with a 24-h diet-
ary recall technique will be used to determine the diet-
ary pattern and the nutrient intake of the participants.
Ten individuals with knowledge of nutrition will be
recruited from various government institutions as “field
staff”. Training will include pre-testing on both 3-day
weighed food records and 24-h dietary recall methodol-
ogies. Twenty participants will be recruited for the pre-
test from another clinic in Lusaka offering ART services
but not involved in the main study.
It is common practice for HIV-infected people to seek
care and support from a health facility far from their
residential catchment area. Therefore, it will be expected
that many participants may be located in a wide range
of residential locations of Lusaka including urban, peri-
urban and rural areas. A well-designed house location
plan will be required. Final updates on the residential
address of each participant will be collected when they
come for the 8-month follow-up visit. A participants’
register to aid clustering based on their residential loca-
tion will be prepared to assist in assigning participants
within close proximity to the same field staff. In addi-
tion to telephone and house numbers, detailed direc-
tions to the participant’s residence will be taken,
including names of nearby landmarks such as schools,
churches, and shops. It is also important to note the
local names used to identify participants in their local
communities. For example, it is common for women in
Zambia to be called by their children or husband’s
names.
Visiting participants in their home might not be
acceptable as some participants might not wish to dis-
close their HIV status to some or all members of their
household. Participants will be assured that the all diet-
ary intake data will be collected by non-medical person-
nel. This component of the study will be led by the
National Food and Nutrition Commission which is well
known as an institution responsible for promoting the
nutrition agenda in the country which should help to
minimize any potential stigma.
A total of 200 participants will be recruited for the
study and a drop-out rate of 20% is anticipated. Accord-
ingly, we anticipate that dietary intake data will be col-
lected from approximately 160 participants. Each field
staff member will be assigned 2 participants per day
therefore we anticipate that data collection will take
about two months to complete. Each participant will be
contacted a week before data collection to remind them
of the visit by field staff. Wherever possible, an under-
standing of level of literacy will be established before-
hand. For participants who are unable to read and write,
somebody in the household will need to be identified to
record for them.
Field staff will train two participants per day, one in
the morning and the second in the afternoon. This will
be done on Mondays while Tuesday, Thursday and
Saturday (or Sunday for Seventh Day Adventists) will be
the 3 days during which the participants will be record-
ing their food intake. On the second day (Wednesdays)
the field staff will visit the participant’s home to conduct
a 24-h dietary recall. This will be done to assess the cor-
rect observance of the diet records, after keeping the
record for one week day. The results of which will be
immediately compared with those recorded for one day
and will be the basis for reinforcing what will be dis-
cussed during the training. All forms and the food scales
will be collected on Sundays, or Mondays for Seventh
Day Adventists. Five supervisors will pay random visits
to participant’s homes to check on the accuracy and
completeness of recording.
Demographics
A questionnaire to assess demographic information will
be completed by each participant on the day of recruit-
ment and include questions on age, educational level,
marital and socioeconomic status, and length of time
they have known about their HIV status.
Data management and entry
All measurements will be entered on forms specifically
designed for the project. Due to the number of mea-
surements, forms of different colours will be used for
easy identification. Completed forms will be checked for
completeness by the PI or any other NISIR project staff
present at the clinic. Each clinic will maintain separate
files with all files stored safely by the PI.
Clinical assessment data including micronutrient ana-
lysis and socio-demographic assessment will be entered
using EPI-INFO software (Centres for Disease Control
and Prevention, Atlanta GA) while BIA, skinfold thick-
ness, circumference and TBW measurements will be
entered in Excel data sheets. Dietary intake forms will
be checked for completeness by the supervisors at
NFNC. A spread sheet in Excel 2007 will be created in
which raw data from the record forms consisting of the
foods and amounts consumed will be entered. Data
bases containing nutrients to be used in the analysis will
be created using food composition tables for Zambia
[18], Food and Agriculture Organisation [19] and Mali
[20,21]. Recipe databases will be created using values
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from the 2009 NFNC study and the Uganda/HarvestPlus
databases. Then the data base containing nutrients from
the food composition tables will be merged with those
containing the foods and amounts consumed to calcu-
late the nutrient intake.
Sample size calculation
The sample size calculations were based on detecting a
5% weight change between groups over the 12-month
period. Assuming a 10% variance in the within-group
body weight, 37 participants are needed in each group
to detect this difference with an alpha of 0.05 and a
power of 90%. If the attrition is 25% over the year, a
minimum of 48 participants are required in each group.
Assuming FFM is 35% of the weight gain [22], 44 parti-
cipants are needed in each group to detect this differ-
ence with an alpha of 0.05 and a power of 90%. If the
attrition is 25% over the year, a minimum of 58 partici-
pants are required in each group. It is uncertain what
magnitude of change is expected in CD4 counts and
viral load. For a moderate effect size (Cohen’s d = 0.4)
66 participants are needed in each group to detect this
difference with an alpha of 0.05 and a power of 90%. If
the attrition is 25% over the year, a minimum of 88 par-
ticipants are required in each group.
Statistical Analysis plan
Statistical analyses will be performed using SAS software
(SAS Institute, Cary, NC, USA). Descriptive statistics
will be provided for the nutritional status, body compo-
sition, clinical and socio-demographic characteristics of
the participants at baseline, 4, 8 and 12 months follow-
up. At baseline, the characteristics of participants on
food supplement and those without food supplement
will be compared using t-test for continuous variables
and Fisher’s Exact Test for categorical variables.
Repeated measures analysis of variance (RM-ANOVA)
will be employed to compare the primary outcome vari-
ables (nutritional status and body composition) in parti-
cipants with and without food supplements. Where
confounding variables may need to be account for,
adjustment will be made by covariance.
Discussion
Few studies have used comprehensive anthropometric
and criterion body composition assessment techniques
to assess the impact of food supplements in Zambian
HIV-infected women receiving ARV treatment and
indeed elsewhere in sub-Saharan Africa. The outcome
of this study will thus provide Zambia and the region
with valuable information that will help guide the devel-
opment of appropriate nutrition guidelines for PLHA,
especially in the context of the risk for obesity and the
metabolic syndrome in this population.
BIA is a rapid, inexpensive and non-invasive method
to measure body composition and of particular interest
for field and clinical studies in this setting. The ability
to utilise criterion measures of nutritional status in
these people will provide important information to
inform more appropriate nutritional interventions and
the provision of improved clinical care and support
using validated approaches.
Despite the potential benefits of the BIA technique, a
limitation is the inability to identify site-specific altera-
tions in body fat, a particular issue in PLHA [23]. Skin-
fold thickness measurements provide information on
regional and whole body composition and hence may be
approach to consider visceral fat accumulation and fat
loss from limbs, of clinical concern due to the relation-
ship with insulin resistance and other serious metabolic
disturbances [24].
One of the limitations of the proposed study is that
only female participants will be included. Due to gender
differences in body composition and HIV-associated
wasting, results will not be readily applicable to HIV-
infected males [25] and children.
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